Yangjisa Co., Ltd. (KOSDAQ:030960)
7,290.00
+70.00 (0.97%)
At close: Mar 18, 2026
Yangjisa Revenue
Yangjisa had revenue of 6.65B KRW in the quarter ending March 31, 2022, a decrease of -68.76%. This brings the company's revenue in the last twelve months to 45.16B, down -7.33% year-over-year. In the fiscal year ending June 30, 2012, Yangjisa had annual revenue of 51.69B with 10.55% growth.
Revenue (ttm)
45.16B
Revenue Growth
-7.33%
P/S Ratio
2.22
Revenue / Employee
125.79M
Employees
320
Market Cap
100.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2012 | 51.69B | 4.93B | 10.55% |
| Jun 30, 2011 | 46.75B | 433.81M | 0.94% |
| Jun 30, 2010 | 46.32B | 271.88M | 0.59% |
| Jun 30, 2009 | 46.05B | 5.05B | 12.32% |
| Jun 30, 2008 | 41.00B | 459.95M | 1.13% |
| Jun 30, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Theragen Etex | 268.13B |
| Daejung Chemicals & Metals | 104.05B |
| Amicogen | 87.97B |
| Sam-A Pharm. | 76.66B |
| Stormtec | 73.19B |
| Daechang Solution | 59.77B |
| HUMAN TECHNOLOGY | 49.31B |
| ALT Co., Ltd | 43.21B |